Health Care Professionals, Researchers, & Study Sponsors
New therapies for epilepsy, including medications, medical devices and surgical procedures, are under active evaluation around the country in clinical trials. Physicians are often asked by their patients with epilepsy about available clinical trials. Therefore, as part of our service to you, epilepsy.com now provides an integrated listing of ongoing clinical trials provided to Centerwatch or epilepsy.com directly in our Research Studies Directory below. Patients can also obtain information from the National Institute of Neurological Disorders and Stroke in Bethesda, Maryland as well as many pharmaceutical, biotech and medical device companies, universities and other organizations.
Memo to: Study Sponsors, Investigators, Epilepsy Center Directors
Epilepsy.com posts listings of IRB-approved epilepsy clinical trials that are actively enrolling subjects. Any Investigator wishing to post a description of an epilepsy study should complete the attached form. Listings for multi-center studies should be submitted only once by the study manager to avoid duplication. Provide an individual listing application for each site, listing the same title and identifying number for the clinical trial so readers will know this is the same study being performed at multiple locations. Individual applications are needed because the information will be grouped by location as well as by study.
Listings are subject to review by epilepsy.com editors, who reserve the right not to post a submission or to revise or remove a listing at their discretion at any time. Epilepsy.com is not responsible for errors in listings.
It is the responsibility of Principal Investigators to be sure that their study has received full approval by an accredited IRB and that their IRB has also approved the epilepsy.com listing for their study site. epilepsy.com assumes no responsibility for these determinations. It is also the responsibility of the Principal Investigator to notify epilepsy.com in the event that any of the listed information changes or enrollment is halted or suspended.
Listings will automatically be terminated on the ending date of the IRB approval unless a new IRB-approved ending date is provided to epilepsy.com.
Levels of Service:
© 2013 Epilepsy.com. All rights reserved.